Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nasal spray
Pharma
FDA signs off on Milestone's heart arrhythmia nasal spray
The FDA has approved Milestone's Cardamyst, a nasal spray to quell episodes from paroxysmal supraventricular tachycardia, an abnormal heart rhythm.
Kevin Dunleavy
Dec 15, 2025 8:20am
Germany's LTS boosts US drug delivery CDMO footprint through M&A
Oct 13, 2025 10:49am
FDA approves Corstasis' nasal spray as treatment for edema
Sep 15, 2025 3:33pm
FDA rejects Milestone’s nasal spray citing manufacturing issues
Mar 28, 2025 8:42am
Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M
Mar 20, 2025 11:23am
Emergent launches OTC overdose drug so 'anyone can save a life'
Aug 31, 2023 9:55am
